Influence of peroxisome proliferator-activated receptor γ gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients

Journal of Neural Transmission

Volumn 112, Issue 10, 2005, Pages 1381-1389

  Sauder, S ^a   Kolsch H ^a   Lutjohann D ^a   Schulz, A ^a   Von Bergmann, K ^a   Maier, W ^a   Heun, R ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

24S hydroxycholesterol; Alzheimer's disease; Cholesterol metabolism; PPAR

Indexed keywords

CHOLESTEROL DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; AGED; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYDROXYCHOLESTEROLS; MALE; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; PPAR GAMMA; RISK FACTORS;

EID: 25144444278     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-004-0267-z     Document Type: Article

References (38)

1. D Altshuler JN Hirschhorn M Klannemark CM Lindgren MC Hohl J Nemesh CR Lane SF Schaffner S Bolk C Brewer T Tuomi D Gaudet TJ Hudson M Daly L Groop ES Lander 2000 The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26 76 80
2. BA Beamer CJ Yen RE Andersen D Muller D Elahi LJ Cheskin R Andres J Roth AR Shuldiner 1998 Association of the Pro12Ala variant in the peroxysome proliferator activated γ2 gene with obesity in two Caucasian population. Diabetes 47 1806 1808
3. I Björkhem D Lütjohann O Breuer A Sakinis A Wennmalm 1997 Importance of a novel oxidative mechanism for elimination of brain cholesterol. J Biol Chem 48 30178 30184
4. L Bretillon A Siden LO Wahlund D Lütjohann L Minthon M Crisby J Hillert CG Groth U Diczfalusy I Bjorkhem 2000 Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci Lett 293 87 90
5. S Brune H Kölsch U Ptok M Majores A Schulz R Schlosser ML Rao W Maier R Heun 2003 Polymorphism in the peroxysome proliferator-activated receptor α gene influences the risk for Alzheimer's disease. J Neural Transm 110 1041 1050
6. EH Corder AM Saunders WJ Strittmatter DE Schmechel GW Gaskell GW Small AD Roses JL Haines MA Pericak-Vance 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 921 923
7. S Craft SE Dagogo-Jack BV Wiethop C Murphy RT Nevins S Fleischmann 1993 Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. Behav Neurosci 107 926 940
8. C Dreyer G Kreg H Keller F Givel G Helftenbein W Wahli 1992 Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68 879 887
9. S Dzeletovic O Breuer E Lund U Diczfalusy 1995 Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem 225 73 80
10. L Fajas JC Fruchart J Auwerx 1998 Transcriptional control of adipogenesis. Curr Opin Cell Biol 10 165 173
11. L Fröhlich D Blum-Degen S Hoyer P Riederer 1996 Regional distribution of insulin, insulin receptors and IGF receptors in post mortem brain cortex in aging and in dementia of Alzheimer type. Neurobiol Aging 17 184
12. ME Greene B Blumberg OW McBride HF Yi K Kronquist K Kwan L Hsieh G Greene SD Nimer 1995 Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr 4 281 299
13. J Hixson DT Vernier 1990 Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 31 545 548
14. H Jick GL Zornberg SS Jick S Seshadri DA Drachman 2000 Statins and the risk of dementia. Lancet 356 1627 1631
15. S Kalmijn LJ Launer A Ott JC Witteman A Hofman MM Breteler 1997 Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42 776 782
16. M Kivipelto EL Helkala MP Laakso T Hanninen M Hallikainen K Alhainen H Soininen J Tuomilehto A Nissinen 2001 Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322 1447 1451
17. H Kölsch R Heun A Kerksiek K von Bergmann W Maier D Lütjohann 2004 Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. Neurosci Lett 368 303 308
18. D Lütjohann O Breuer G Ahlborg I Nennesmo Å Sidén U Dicfalusy I Björkhem 1996 Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci USA 93 9799 9804
19. D Lütjohann A Papassotiropoulos I Björkhem S Locatelli M Bagli RD Oehring U Schlegel F Jessen ML Rao K von Bergmann R Heun 2000 Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res 41 195 198
20. EG Lund JM Guileyardo DW Russell 1999 cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci USA 96 7238 7243
21. M Marrapodi JY Chiang 2000 Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J Lipid Res 41 514 520
22. G McKhann D Drachman M Folstein R Katzman D Price EM Stadlan 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 939 944
23. A Meirhaeghe L Fajas N Helbecque D Cottel P Lebel J Dallongeville S Deeb J Auwerx P Amouyel 1998 A genetic polymorphism of the peroxysome proliferator-activated receptor γ gene influences plasma leptin levels in obese humans. Hum Mol Genet 7 435 440
24. GS Meneilly A Hill 1993 Alterations in glucose metabolism in patients with Alzheimer's disease. J Am Geriatr 41 710 714
25. Y Mori H Kim-Motoyama T Katakura K Yasuda H Kadowaki BA Beamer AR Shuldiner Y Akanuma Y Yazaki T Kadowaki 1998 Effect of the Pro12Ala variant of the human peroxysome proliferator-activated receptor γ2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese man. Biochem Biophys Res Commun 251 195 198
26. IL Notkola R Sulkava J Pekkanen T Erkinjuntti C Ehnholm P Kivinen J Tuomilehto A Nissinen 1998 Serum total cholesterol, apolipoprotein E ε4 allele, and Alzheimer's disease. Neuroepid 17 14 20
27. M Ristow D Muller-Wieland A Pfeiffer W Krone CR Kahn 1998 Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med 339 953 959
28. R Roduit J Morin F Masse L Segall E Roche CB Newgard F Assimacopoulos-Jeannet M Prentki 2000 Glucose down-regulates the expression of the peroxisome proliferator-activated receptor-alpha gene in the pancreatic beta-cell. J Biol Chem 275 35799 35806
29. AM Saunders K Schmader JC Breitner MD Benson WT Brown L Goldfarb D Goldgaber MG Manwaring MH Szymanski N McCown KC Dole DE Schmechel WJ Strittmatter MA Pericak-Vance AD Roses 1993 Apolipoprotein E epsilon 4 allele distribution in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342 710 711
30. J Schneider J Kreuzer A Hamann P Nawroth KA Dugi 2002 The prolin 12 alanin substitution in the peroxysome proliferator-activated receptor-γ2 gene is associated with lower lipoprotein lipase activity in vivo. Diabetes 51 867 870
31. K Schoonjans B Staels J Auwerx 1996 Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37 907 925
32. BM Spiegelman 1997 Peroxisome proliferator-activated receptor gamma: a key regulator of adipogenesis and systemic insulin sensitivity. Eur J Med Res 2 457 464
33. BM Spiegelman 1998 PPARγ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47 507 514
34. P Tontonoz E Hu RA Graves AI Budvari BM Spiegelman 1994 m-PPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8 1224 1234
35. A Vidal-Puig R Considine M Jimenez-Linan A Werman WJ Pories JF Caro JS Flier 1997 Peroxysome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99 2416 2422
36. A Werman A Hollenberg G Solanes C Bjorbaek AJ Vidal-Puig JS Flier 1997 Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor (PPAR). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin. J Biol Chem 272 20230 20235
37. B Wolozin W Kellman P Ruosseau GG Celesia G Siegel 2000 Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57 1439 1443
38. Y Zhu C Qi J Korenberg XN Chen D Noya MS Rao JK Reddy 1995 Structural organisation of mouse peroxisome proliferator-activated receptor γ (m PPAR γ)gene: alternative promoter use and different splicing yield two PPAR γ isoforms. Proc Natl Acad Sci USA 92 7921 7925